New Delhi, Oct 10 (IANS) Scientists at the Indian Association for the Cultivation of Science (IACS), Kolkata, an autonomous institute of the Department of Science and Technology, have developed a novel therapy that could be a potential precision medicine especially for those resistant to current cancer remedies.
Cancer cells often develop resistance to some treatments and hence require alternate therapy methods.
The team identified a promising new target for cancer treatment by activating a DNA repair enzyme called TDP1, suggesting a combination therapy.
To find an alternative treatment, the team probed how cancer cells repair DNA during cell division and respond to chemotherapy that targets the enzyme Top1, often leading to drug resistance.
The research published in The EMBO Journal highlights two key proteins — Cyclin-dependent kinase 1 (CDK1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1).
The study showed that cancer cells can counteract the effect of existing drugs by activating TDP1 — a DNA repair enzyme — allowing them to survive, said the team led by Benu Brata Das from the varsity.
“Our work demonstrates that CDK1 directly regulates TDP1, aiding cancer cells in repairing DNA breaks caused by Top1 inhibitors,” Das added.
“By targeting both CDK1 and TDP1, we can potentially overcome resistance and improve treatment effectiveness,” he said.
The study suggests that using CDK1 inhibitors — such as avotaciclib, alvocidib, roniciclib, riviciclib, and dinaciclib — alongside Top1 inhibitors could enhance cancer cell killing.
This combination disrupts DNA repair mechanisms and halts the cell cycle, making it more difficult for cancer cells to survive.
“Cancer cells often develop resistance to single-agent treatments. By using both CDK1 and Top1 inhibitors, we can more effectively target and eliminate cancer cells,” said Das emphasising the potential of this combination therapy.
The study points to a promising avenue for precision medicine in treating cancers, especially those resistant to current therapies.
–IANS
rvt/khz
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
